Impact of 68Ga-DOTATATE Scan on Clinical Care Compared with Days Between Comparison Scans
| Interval between 111In-pentetreotide and 68Ga-DOTATATE scans | ||||||||||||
| 0–30 d | 0–90 d | 91–180 d | >180 d | Interval between CT or MRI and 68Ga-DOTATATE scans | ||||||||
| 111In-pentetreotide, treatment impact | All types | Planar + SPECT/CT | All types | Planar + SPECT/CT | All types | Planar + SPECT/CT | All types | Planar + SPECT/CT | 0–30 d | 0–90 d | 91–180 d | > 180 d |
| None | 1 | 1 | 9 | 4 | 16 | 13 | 25 | 14 | 22 | 33 | 7 | 10 |
| Minor | 2 | 2 | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 6 | 3 | 0 |
| Major | 0 | 0 | 4 | 3 | 4 | 2 | 11 | 6 | 5 | 9 | 4 | 6 |
All 111In-pentetretotide scan types, n = 78, and 111In-pentetretotide with SPECT/CT, n = 48. There was no significant impact on care by time interval between scans.